5 Einträge gefunden

1. Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. Ackermann, Hanns
   7. May, Angelika

   2009 - Forschungsinformationssystem des UKE
2. Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. Ackermann, Hanns
   7. May, Angelika

   2008 - Forschungsinformationssystem des UKE
3. Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. May, Angelika
   7. Knecht, Rainald

   2008 - Forschungsinformationssystem des UKE
4. Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.

   1. Baghi, Mehran
   2. Mack, Martin G
   3. Hambek, Markus
   4. Bisdas, Sotirios
   5. Muerthel, Ramona
   6. Wagenblast, Jens
   7. Gstoettner, Wolfgang

   2007 - Forschungsinformationssystem des UKE
5. Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?

   1. Baghi, Mehran
   2. Mack, Martin G
   3. Wagenblast, Jens
   4. Hambek, Markus
   5. Rieger, Jörg
   6. Bisdas, Sotirios
   7. Gstoettner, Wolfgang

   2007 - Forschungsinformationssystem des UKE